Total item
Cart Subtotal
$0.00 Biological Activity
OSI-930 is a potent inhibitor of Kit, KDR, Flt, CSF-1R, c-Raf and Lck with IC50 of 80 nM, 9 nM, 8 nM, 15 nM, 41 nM and 22 nM, respectively.
Targets
| Target | Value |
|---|---|
| FLT1 | IC50: 8nM |
| KDR | IC50: 9nM |
| CSF-1R | IC50: 15nM |
| LCK | IC50: 22nM |
| C-Raf | IC50: 41nM |
| Kit | IC50: 80nM |
| FLT3 | IC50: 1.303μM |
| PDGFRα | IC50: 3.408μM |
| Abl | IC50: 4.738μM |
| PDGFRβ | IC50: 6.9μM |
| EGFR | IC50: >10μM |
| AuroraA | IC50: >10μM |
| Axl | IC50: >10μM |
| CDK2/CyclinA | IC50: >10μM |
| IKKβ | IC50: >10μM |
| MEK1 | IC50: >10μM |
| PDPK1 | IC50: >10μM |
| PKBβ | IC50: >10μM |
| Tie-2 | IC50: >10μM |
| In vitro (25°C) | DMSO | 89 mg/mL (200.7 mM) | |
| Water | <1 mg/mL (<1 mM) | ||
| Ethanol | 3 mg/mL (6.76 mM) | ||
| In vivo | 30% PEG400/0.5% Tween80/5% propylene glycol | 5 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 22.55 mL | 112.76 mL | 225.53 mL |
| 0.5 mM | 4.51 mL | 22.55 mL | 45.11 mL |
| 1 mM | 2.26 mL | 11.28 mL | 22.55 mL |
| 5 mM | 0.45 mL | 2.26 mL | 4.51 mL |
*The above data is based on the productmolecular weight 443.4 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Catalog Num | A10679 |
|---|---|
| Actions | Inhibitor |
| M. Wt | 443.4 |
| Formula | C22H16F3N3O2S |
| Solubility | DMSO |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 728033-96-3 |
| Synonyms | OSI930 |
| SMILES | C1=CC=C2C(=C1)C(=CC=N2)CNC3=C(SC=C3)C(=O)NC4=CC=C(C=C4)OC(F)(F)F |
Product Tags
Product Questions
Product Questions
No Questions
You may also be interested in the following product(s)
Regorafenib (BAY 73-4506)
Regorafenib (BAY 73-4506) is a multikinase inhibitor with IC50 of 17, 40 and 69 nM c-KIT, VEGFR2, B-Raf. Regorafenib (BAY 73-4506) is an ora…
Taxifolin
Taxifolin is found to bind at the ATP-binding site on VEGFR-2 kinase with large value of binding energy and act as type I competitive inhibi…
SU 5416 (Semaxinib)
SU 5416 is an inhibitor of vascular endothelial growth factor receptor (VEGFR) that also inhibits other tyrosine kinases KIT, MET, FLT3 and …
Tivozanib (AV-951)
Tivozanib (AV-951) is an oral VEGF receptor tyrosine kinase inhibitor that is designed to inhibit all three VEGF receptors.
Ki8751
Ki8751 is a cell-permeable quinolyloxyphenyl-urea compound that acts as a Flk-1 (VEGFR-2)-selective inhibitior in both cell-based and cell-f…
TG 100572
TG 100572 is VEGFR2 and Src kinase inhibitor.
XL647 (Tesevatinib)
XL647 is an orally bioavailable small-molecule RTK inhibitor that binds to and inhibits several tyrosine receptor kinases that play major ro…
(-)-Catechin gallate
(-)-Catechin gallate is an antioxidant constituent of green tea. At uM concentrations, inhibits VEGF-induced tyrosine phosphorylation.
Keywords:buy OSI-930 | OSI-930 Supplier | purchase OSI-930 | OSI-930 cost | OSI-930 manufacturer | order OSI-930 | OSI-930 distributor | buy 728033-96-3| 728033-96-3 Supplier | purchase 728033-96-3 | 728033-96-3 cost | 728033-96-3 manufacturer | order 728033-96-3 | 728033-96-3 distributor
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: [email protected]
Not your Region? View all Distributors
Adooq Quality Guarantee
We promise all products perform as described.